#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antiphospholipid antibodies Congenital nephrogenic diabetes insipidus Hypertriglyceridaemia Angelman's syndrome Essential thrombocythaemia Huntington's disease Acute promyelocytic leukaemia Extra-osseous Ewing's sarcoma Acquired haemophilia Postprandial hypoglycaemia Primary hyperoxaluria Lymphangiosarcoma Oesophageal squamous cell carcinoma stage II Brain injury Hypergammaglobulinaemia benign monoclonal More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis Activated PI3 kinase delta syndrome – Treatment Alport’s syndrome – Life with Disease Basal cell naevus syndrome – Life with Disease Systemic mastocytosis – Trials in Disease Myelodysplastic syndrome with excess blasts – Life with Disease Encephalitis autoimmune – Diagnostics Castleman’s disease – Life with Disease Soft tissue sarcoma – Life with Disease Langerhans cell sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Palopegteriparatide SURVODUTIDE Bi-1910 Ambroxol Hydrochloride Netupitant Posaconazole Technetium (99Mtc) Levobupivacaine Hydrochloride Cx-037231 Levetiracetam SIPAVIBART Resatorvid Salmeterol Xinafoate Fluticasone Furoate Trametinib Ieramilimab Febuxostat Hemihydrate Propranolol Crgd-Zw800-1 More therapies…

    Learn about Your Condition

    Breast angiosarcoma Syphilis Essential hypertension Peripheral artery thrombosis Epstein-Barr virus infection Drug dependence Andersen-Tawil syndrome Acute leukaemia Vulvovaginal dryness Abdominal pain Large cell lung cancer Nephrogenic anaemia Inflammation Hairy cell leukaemia Polycythaemia vera More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glioma

  • Study of Abemaciclib and Temozolomide for Children and Young Adults with Newly Diagnosed High-Grade Glioma After Radiotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Abemaciclib
    • Temozolomide
    Belgium Denmark France Italy The Netherlands Romania +1

  • Study of WT1 LAMP mRNA DC Immunotherapy for Children with High-Grade Glioma and Diffuse Intrinsic Pontine Glioma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Brain stem glioma
    • Glioma
    Investigated Drugs:
    • Wt1 Lamp Mrna Dc
    Belgium

  • Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Glioma
    Investigated Drugs:
    • Fluciclovine (18F)
    • Fluoroethyltyrosine F-18
    Germany

  • Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Primitive neuroectodermal tumour
    • Ewing’s sarcoma
    • Glioma
    Investigated Drugs:
    • Lenvatinib
    Czechia France Italy Spain

  • Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Vorasidenib
    France Germany Italy The Netherlands Spain

  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    • Ependymoma
    • Neuroblastoma
    Investigated Drugs:
    • Vinblastine Sulfate
    • Capecitabine
    • Cyclophosphamide
    France
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!